Is CVS Health Corp (NYSE:CVS) a Valuable Stock?

[PRNewswire] CVS Health Corp (NYSE:CVS)(TREND ANALYSISannounced that it will offer an extensive array of in-store and online resources to assist senior patients in determining the best 2017 Medicare Part D prescription drug plan during the Annual Enrollment period. Open enrollment for Medicare Part D begins October 15 and ends December 7, 2016.

Convenient access to information about local and national Medicare Part D plans will be available to patients – in both English and Spanish – at all 9,600 CVS Pharmacy locations nationwide. In addition, more than 11,000 informational events will be held in select CVS Pharmacy stores across the country during the Open Enrollment period where representatives from local health plans will provide Medicare Part D information to eligible patients and answer any questions they may have.

CVS Pharmacy’s online Health Insurance Information Center, www.cvs.com/Medicare, offers information on available Medicare Part D plans. The website features information that helps seniors find a plan in their community and guides them on how to enroll. For seniors evaluating Medicare Part D plans, they can enter their prescription information and zip code to compare plans available to them. Patients can also find a listing of store informational insurance events in their community.

Stock Performance: Click here for a free comprehensive Trend Analysis Report

CVS Health Corp (NYSE:CVS) stock is currently trading 16.75% below its 52-week-high, 3.97% above its 52-week-low. The 1-year stock price history is in the range of $85.41 – $106.67. CVS Health Corp (CVS) has a price to earnings ratio of 20.43 versus Healthcare sector average of 40.79. CVS stock price has underperformed the S&P 500 by 14.2%. The Retail Drug Store company is currently valued at $94.68 billion, and its share price closed the last trading session at $88.8. The stock has a 50-day moving average of $90.11 and a 200-day moving average of $96.45.

CVS Health Corp (CVS) current short interest stands at 13.62 million shares. It has increased by 3% from the same period of last month. Around 2% of the company’s shares, which are float, are short sold. With a 10-days average volume of 6.1 million shares, the number of days required to cover the short positions stand at 2.3 days.

CVS is forecasted to report earnings per share of $1.57 and a revenue of $45.58 billion for the 3rd Quarter of the fiscal year 2016. CVS Health Corp (CVS) expects to post results on November 08. The Retail Drug Store company announced last quarter earnings per share of $1.32 against a consensus Street estimate of $1.30, beating the average estimate by $0.02. The company posted a revenue of $43.73 billion compared to an estimation of $44.23 billion.

Is this a Trading Opportunity? Click here for a free Trend Analysis Report

There are currently twenty-five analysts that cover CVS Health Corp stock. Of those twenty-five, twenty-one have a Buy rating, four have a Hold rating. On a consensus basis this yields to a Buy rating. The consensus target price stands at $109.83.

A recent analyst activity consisted of UBS who initiated their coverage on the stock with Buy rating on October 6. UBS fixed their price target at $107. This corresponds to a 20.5% upside from the last closing price. On the date of report, the stock closed at $86.49.

Credit Suisse reiterated their Outperform stance on October 3, and decreased their price target from $115 to $110. This corresponds to a 23.87% upside from the last closing price. On the date of report, the stock closed at $87.09.

Another research firm was Leerink Partners who reiterated their Outperform stance on September 30. Leerink Partners decreased price target from $110 to $105. This translates to a 18.24% upside from the last closing price. On the date of report, the stock closed at $88.99.

Company snapshot

CVS Health Corporation is an integrated pharmacy health care provider. The Company’s offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.

Is CVS Health Corp (NYSE:CVS) a Valuable Stock? was last modified: October 17th, 2016 by Steven Finley